ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Carboplatin

Also written as “carboplatin”, “Pemetrexed/Carboplatin” and “CARBOPLATIN”.

Its studies are mostly in Carcinoma, Non-Small-Cell Lung · Ovarian Neoplasms · Breast Neoplasms · Small Cell Lung Carcinoma · Neoplasms, led by 31 companies.

Drug pageCarboplatin: every studyMany companies study it; this page follows only the 89 they lead. All 1,229 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Nov 24, 200989 company-led studies, 5 open or runningNext primary completion: Dec 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Eli Lilly300 open or runningphase 4since Nov 24, 2009Apr 30, 2002none ahead
Bristol-Myers Squibbits history only140 open or runningphase 4since May 28, 2014Sep 13, 2001none ahead
Sanofiits history only70 open or runningphase 3since Jul 11, 2001Jul 11, 2001none ahead
Sarah Cannon Research Instituteits history only31 open or runningphase 2since Nov 2, 2005Nov 2, 2005none ahead
Swedish Orphan Biovitrumits history only30 open or runningphase 3since Feb 5, 2003Feb 5, 2003none ahead
AGO Researchits history only20 open or runningphase 3since Apr 16, 2013Apr 16, 2013none ahead
CarTheraits history only21 open or runningphase 3since Jun 5, 2023Nov 13, 2018Jan 28, 2028phase 3 · NCT05902169
Eisaiits history only20 open or runningphase 3since Dec 31, 2002Dec 31, 2002none ahead
InSightecits history only20 open or runningphase 2since Jun 1, 2020Jun 1, 2020none ahead
Ionis Pharmaceuticalsits history only20 open or runningphase 3since Jun 6, 2001Jun 6, 2001none ahead

Also a collaborator on its studies: Jazz Pharmaceuticals Ireland, Daiichi Sankyo, AstraZeneca, Merck, Parexel, Arcus Biosciences, Ono Pharmaceutical, Pfizer, Novotech (Australia) Pty, WuXi CDS Clinical Research (Shanghai), Valerio Therapeutics, Ortho Biotech, Tibotec Pharmaceutical and Medarex.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Eli Lilly only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 13 studies since Apr 30, 2002.

  1. Dec 21, 2005Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00269152 · 122 enrolled · France, Germany, Spain
  2. May 10, 2006Phase 2 study in Breast NeoplasmsNCT00325234 · 135 enrolled · Germany, Italy, South Africa and more
  3. Jun 20, 2006Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00343291 · 121 enrolled · United States
  4. Jul 10, 20062 phase 2 studiesNCT00350792, NCT00356525
  5. Nov 17, 2006Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00402051 · 133 enrolled · Germany
  6. May 31, 2007Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00482014 · 120 enrolled · United States, India
  7. Jun 21, 20072 phase 2 studiesNCT00490711, NCT00494026
  8. Nov 24, 2009Phase 4 study in Carcinoma, Non-Small-Cell LungNCT01020786 · 109 enrolled · Japan
  9. Feb 3, 2010Phase 2 study in Head and Neck NeoplasmsNCT01063075 · 34 enrolled · United States, Canada
  10. Mar 3, 20102 phase 2 studies in Head and Neck NeoplasmsNCT01081041, NCT01087970
  11. Jul 8, 2010Phase 2 study in Carcinoma, Non-Small-Cell LungNCT01160744 · 280 enrolled · United States, Belgium, Canada and more
  12. Sep 30, 2011Phase 1 study in GliomaNCT01445119 · 58 enrolled · United States
  13. Mar 16, 2015Phase 2 study in CarcinomaNCT02392507 · 54 enrolled · United States
  14. Oct 20, 2016Phase 2 study in Thoracic NeoplasmsNCT02941601 · United States, Belgium, Germany and more

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 30 Eli Lilly leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02941601Thoracic Neoplasms · United States, Belgium, Germany and more2WithdrawnDec 20170
NCT02392507Carcinoma · United States2CompletedJan 29, 201854
NCT01445119Glioma · United States1CompletedJul 201358
NCT01160744Carcinoma, Non-Small-Cell Lung · United States, Belgium, Canada and more2CompletedJan 2014280
NCT01087970Head and Neck Neoplasms · United States2CompletedAug 201369
NCT01081041Head and Neck Neoplasms · United States, Canada, Mexico2CompletedAug 2013187
NCT01063075Head and Neck Neoplasms · United States, Canada2CompletedMay 201534
NCT01020786Carcinoma, Non-Small-Cell Lung · Japan4CompletedMar 2011109
NCT00494026Small Cell Lung Carcinoma · Italy, Poland, Spain and more2TerminatedOct 20084
NCT00490711Carcinoma, Ovarian Epithelial · Slovakia2Completed7
NCT00482014Carcinoma, Non-Small-Cell Lung · United States, India2CompletedOct 2011120
NCT00402051Carcinoma, Non-Small-Cell Lung · Germany2CompletedDec 2008133
NCT00356525Lung Neoplasms · United States, Brazil, India2TerminatedJun 200841
NCT00350792Carcinoma, Non-Small-Cell Lung · France2CompletedNov 200862
NCT00343291Carcinoma, Non-Small-Cell Lung · United States2CompletedMay 2010121
NCT00325234Breast Neoplasms · Germany, Italy, South Africa and more2CompletedApr 2010135
NCT00269152Carcinoma, Non-Small-Cell Lung · France, Germany, Spain2CompletedNov 2007122
NCT00191854Breast Neoplasms · Brazil, China, India and more2CompletedAug 2008147
NCT00191451Breast Neoplasms · United States2CompletedOct 2008150
NCT00191256Carcinoma, Non-Small-Cell Lung · United States2Completed77
NCT00191230Carcinoma, Non-Small-Cell Lung · United States2Completed70
NCT00190710Carcinoma, Non-Small-Cell Lung · United States3Completed242
NCT00097227Carcinoma, Non-Small-Cell Lung · United States2CompletedApr 2007165
NCT00097214Carcinoma, Non-Small-Cell Lung · United States2CompletedApr 200757
NCT00072865Breast Neoplasms · Russian Federation2Completed50
NCT00063401Ovarian Neoplasms · United States2CompletedJun 200639
NCT00051506Lung Neoplasms · United States2Completed
NCT00051493Carcinoma, Non-Small-Cell Lung · United States2Completed50
NCT00042679Carcinoma, Non-Small-Cell Lung · United States2Completed
NCT00034541Carcinoma, Non-Small-Cell Lung · United States2CompletedMay 200332

How it is read

Names in the registry

  • “Carboplatin”, 110 entries
  • “carboplatin”, 38 entries
  • “Pemetrexed/Carboplatin”, 2 entries
  • “CARBOPLATIN”, 2 entries
  • “Carboplatin/Paclitaxel”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.